T1	Participants 248 407	individuals with spinal cord injury (SCI) enrolled in a randomized controlled trial (RCT) on the efficacy of venlafaxine XR for major depressive disorder (MDD)
T2	Participants 725 817	Six Departments of Physical Medicine and Rehabilitation in university-based medical schools.
T3	Participants 831 962	Individuals (N=123) with SCI and major depression between 18 and 64 years of age, at least 1 month post-SCI who also reported pain.
